Stem Cell Manufacturing Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029

6.82%
CAGR (2023-2029)
15.29 USD Bn.
Market Size
312
Report Pages
148
Market Tables

Overview

Global Stem Cell Manufacturing Market is expected to grow at a CAGR of 6.82% during the forecast period. Global Stem Cell Manufacturing Market is expected to reach US$ 24.28 Bn. by 2029.

Stem Cell Reconstructive Market Dynamics

The Research Report gives an in-depth account of the drivers and restraints in the stem cell reconstructive market. Stem cell reconstructive surgery includes the treatment of injured or dented part of body. Stem cells are undifferentiated biological cells, which divide to produce more stem cells.Stem Cell Manufacturing MarketTo know about the Research Methodology :- Request Free Sample Report

Growing reconstructive surgeries led by the rising number of limbs elimination and implants and accidents are boosting the growth in the stem cell reconstructive market. Additionally, rising number of aged population, number of patients suffering from chronic diseases, and unceasing development in the technology, these are factors which promoting the growth of the stem cell reconstructive market. Stem cell reconstructive is a procedure containing the use of a patient's own adipose tissue to rise the fat volume in the area of reconstruction and therefore helping 3Dimentional reconstruction in patients who have experienced a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or reconstructive surgery as a result of an accident or injury.

The Stem cell reconstructive surgeries are also used in plastic or cosmetic surgeries as well. Stem cell and regenerative therapies gives many opportunities for development in the practice of medicine and the possibility of an array of novel treatment options for patients experiencing a variety of symptoms and conditions. Stem cell therapy, also recognised as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.

The common guarantee of all the undifferentiated embryonic stem cells (ESCs), foetal, amniotic, UCB, and adult stem cell types is their indefinite self-renewal capacity and high multilineage differentiation potential that confer them a primitive and dynamic role throughout the developmental process and the lifespan in adult mammal.
However, the high expenditure of stem cell reconstructive surgeries and strict regulatory approvals are restraining the market growth.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Stem Cell Reconstructive Market Segment analysis

Based on Cell Type, the embryonic stem cells segment is expected to grow at a CAGR of xx% during the forecast period. Embryonic stem cells (ESCs), derived from the blastocyst stage of early mammalian embryos, are distinguished by their capability to distinguish into any embryonic cell type and by their ability to self-renew. Owing to their plasticity and potentially limitless capacity for self-renewal, embryonic stem cell therapies have been suggested for regenerative medicine and tissue replacement after injury or disease.

Additionally, their potential in regenerative medicine, embryonic stem cells provide a possible another source of tissue/organs which serves as a possible solution to the donor shortage dilemma. Researchers have differentiated ESCs into dopamine-producing cells with the hope that these neurons could be used in the treatment of Parkinson’s disease. Upsurge occurrence of cardiac and malignant diseases is promoting the segment growth. Rapid developments in this vertical contain protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, establishment of several disease models, and evaluation of therapeutic potential in treating incurable diseases.

Regional analysis

The North American region has dominated the market with US$ xx Mn. America accounts for the largest and fastest-growing market of stem cell reconstructive because of the huge patient population and well-built healthcare sector. America's stem cell reconstructive market is segmented into two major regions such as North America and South America. More than 80% of the market is shared by North America due to the presence of the US and Canada.

Europe accounts for the second-largest market which is followed by the Asia Pacific. Germany and UK account for the major share in the European market due to government support for research and development, well-developed technology and high healthcare expenditure have fuelled the growth of the market. This growing occurrence of cancer and diabetes in America is the main boosting factor for the growth of this market.

The objective of the report is to present a comprehensive analysis of the Global Stem Cell Reconstructive Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Stem Cell Reconstructive Market dynamics, structure by analysing the market segments and projects the Global market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.

Global Stem Cell Reconstructive Market Scope : Inquire before buying

Global Stem Cell Manufacturing Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 15.29 Bn.
Forecast Period 2023 to 2029 CAGR: 6.82% Market Size in 2029: US $ 24.28 Bn.
Segments Covered: by Sources Allogeneic
Autologous
Bone Marrow
Adipose Tissue
Blood
Syngeneic
Other
by Cell Type Embryonic Stem Cell
Adult Stem Cell
by Application Cancer
Diabetes
Traumatic Skin Defect
Severe Burn
Other
by End-User Hospitals
Research Institute
Others

Stem Cell Reconstructive Market, By Regions

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Stem Cell Reconstructive Market Key Players are:

1. Osiris Therapeutics
2. NuVasives
3. Cytori Therapeutics
4. Takeda (TiGenix)
5. Cynata
6. Celyad
7. Medi-post
8. Anterogen
9. Molmed
10. Baxter
11. Eleveflow
12. Mesoblast Ltd.
13. Micronit Microfluidics
14. TAKARA BIO INC.
15. Tigenix
16. Capricor Therapeutics
17. Astellas Pharma US, Inc.
18. Pfizer Inc.
19. STEMCELL Technologies Inc.
20. Pfizer Inc.
21. StemCells Inc
22. Caladrius

Frequently Asked questions

1. What is the market size of the Global Stem Cell Manufacturing Market in 2022?
Ans. The market size Global market in 2022 was US$ 15.29 Billion.

2. What are the different segments of the Global Stem Cell Manufacturing Market?
Ans. The Global market is divided into Sources, Cell Type, Application and End-User.

3. What is the study period of this market?
Ans. The Global market will be studied from 2022 to 2029.

4. Which region is expected to hold the highest Global Stem Cell Manufacturing Market share?
Ans. The Asia Pacific dominates the market share in the  market.

5. What  is the Forecast Period of Global Stem Cell Manufacturing Market?
Ans. The Forecast Period of the market is 2023-2029 in the market.

Table of Contents

Global Stem Cell Reconstructive Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Stem Cell Reconstructive Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Stem Cell Reconstructive Market Analysis and Forecast 6.1. Stem Cell Reconstructive Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Stem Cell Reconstructive Market Analysis and Forecast, By Sources 7.1. Introduction and Definition 7.2. Key Findings 7.3. Stem Cell Reconstructive Market Value Share Analysis, By Sources 7.4. Stem Cell Reconstructive Market Size (US$ Mn) Forecast, By Sources 7.5. Stem Cell Reconstructive Market Analysis, By Sources 7.6. Stem Cell Reconstructive Market Attractiveness Analysis, By Sources 8. Global Stem Cell Reconstructive Market Analysis and Forecast, By Cell Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 8.4. Stem Cell Reconstructive Market Size (US$ Mn) Forecast, By Cell Type 8.5. Stem Cell Reconstructive Market Analysis, By Cell Type 8.6. Stem Cell Reconstructive Market Attractiveness Analysis, By Cell Type 9. Global Stem Cell Reconstructive Market Analysis and Forecast, By End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Stem Cell Reconstructive Market Value Share Analysis, By End-User 9.4. Stem Cell Reconstructive Market Size (US$ Mn) Forecast, By End-User 9.5. Stem Cell Reconstructive Market Analysis, By End-User 9.6. Stem Cell Reconstructive Market Attractiveness Analysis, By End-User 10. Global Stem Cell Reconstructive Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Stem Cell Reconstructive Market Value Share Analysis, By Application 10.4. Stem Cell Reconstructive Market Size (US$ Mn) Forecast, By Application 10.5. Stem Cell Reconstructive Market Analysis, By Application 10.6. Stem Cell Reconstructive Market Attractiveness Analysis, By Application 11. Global Stem Cell Reconstructive Market Analysis, By Region 11.1. Stem Cell Reconstructive Market Value Share Analysis, by Region 11.2. Stem Cell Reconstructive Market Size (US$ Mn) Forecast, by Region 11.3. Stem Cell Reconstructive Market Attractiveness Analysis, by Region 12. North America Stem Cell Reconstructive Market Analysis 12.1. Key Findings 12.2. North America Stem Cell Reconstructive Market Overview 12.3. North America Stem Cell Reconstructive Market Value Share Analysis, By Sources 12.4. North America Stem Cell Reconstructive Market Forecast, By Sources 12.4.1. Allogeneic 12.4.2. Autologous 12.4.2.1. Bone Marrow 12.4.2.2. Adipose Tissue 12.4.2.3. Blood 12.4.3. Syngeneic 12.4.4. Other 12.5. North America Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 12.6. North America Stem Cell Reconstructive Market Forecast, By Cell Type 12.6.1. Embryonic Stem Cell 12.6.2. Adult Stem Cell 12.7. North America Stem Cell Reconstructive Market Value Share Analysis, By End-User 12.8. North America Stem Cell Reconstructive Market Forecast, By End-User 12.8.1. Hospitals 12.8.2. Research Institute 12.8.3. Others 12.9. North America Stem Cell Reconstructive Market Value Share Analysis, By Application 12.10. North America Stem Cell Reconstructive Market Forecast, By Application 12.10.1. Cancer 12.10.2. Diabetes 12.10.3. Traumatic Skin Defect 12.10.4. Severe Burn 12.10.5. Other 12.11. North America Stem Cell Reconstructive Market Value Share Analysis, by Country 12.12. North America Stem Cell Reconstructive Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Stem Cell Reconstructive Market Analysis, by Country 12.14. U.S. Stem Cell Reconstructive Market Forecast, By Sources 12.14.1. Allogeneic 12.14.2. Autologous 12.14.2.1. Bone Marrow 12.14.2.2. Adipose Tissue 12.14.2.3. Blood 12.14.3. Syngeneic 12.14.4. Other 12.15. U.S. Stem Cell Reconstructive Market Forecast, By Cell Type 12.15.1. Embryonic Stem Cell 12.15.2. Adult Stem Cell 12.16. U.S. Stem Cell Reconstructive Market Forecast, By End-User 12.16.1. Hospitals 12.16.2. Research Institute 12.16.3. Others 12.17. U.S. Stem Cell Reconstructive Market Forecast, By Application 12.17.1. Cancer 12.17.2. Diabetes 12.17.3. Traumatic Skin Defect 12.17.4. Severe Burn 12.17.5. Other 12.18. Canada Stem Cell Reconstructive Market Forecast, By Sources 12.18.1. Allogeneic 12.18.2. Autologous 12.18.2.1. Bone Marrow 12.18.2.2. Adipose Tissue 12.18.2.3. Blood 12.18.3. Syngeneic 12.18.4. Other 12.19. Canada Stem Cell Reconstructive Market Forecast, By Cell Type 12.19.1. Embryonic Stem Cell 12.19.2. Adult Stem Cell 12.20. Canada Stem Cell Reconstructive Market Forecast, By End-User 12.20.1. Hospitals 12.20.2. Research Institute 12.20.3. Others 12.21. Canada Stem Cell Reconstructive Market Forecast, By Application 12.21.1. Cancer 12.21.2. Diabetes 12.21.3. Traumatic Skin Defect 12.21.4. Severe Burn 12.21.5. Other 12.22. North America Stem Cell Reconstructive Market Attractiveness Analysis 12.22.1. By Sources 12.22.2. By Cell Type 12.22.3. By End-User 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Stem Cell Reconstructive Market Analysis 13.1. Key Findings 13.2. Europe Stem Cell Reconstructive Market Overview 13.3. Europe Stem Cell Reconstructive Market Value Share Analysis, By Sources 13.4. Europe Stem Cell Reconstructive Market Forecast, By Sources 13.4.1. Allogeneic 13.4.2. Autologous 13.4.2.1. Bone Marrow 13.4.2.2. Adipose Tissue 13.4.2.3. Blood 13.4.3. Syngeneic 13.4.4. Other 13.5. Europe Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 13.6. Europe Stem Cell Reconstructive Market Forecast, By Cell Type 13.6.1. Embryonic Stem Cell 13.6.2. Adult Stem Cell 13.7. Europe Stem Cell Reconstructive Market Value Share Analysis, By End-User 13.8. Europe Stem Cell Reconstructive Market Forecast, By End-User 13.8.1. Hospitals 13.8.2. Research Institute 13.8.3. Others 13.9. Europe Stem Cell Reconstructive Market Value Share Analysis, By Application 13.10. Europe Stem Cell Reconstructive Market Forecast, By Application 13.10.1. Cancer 13.10.2. Diabetes 13.10.3. Traumatic Skin Defect 13.10.4. Severe Burn 13.10.5. Other 13.11. Europe Stem Cell Reconstructive Market Value Share Analysis, by Country 13.12. Europe Stem Cell Reconstructive Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Stem Cell Reconstructive Market Analysis, by Country 13.14. Germany Stem Cell Reconstructive Market Forecast, By Sources 13.14.1. Allogeneic 13.14.2. Autologous 13.14.2.1. Bone Marrow 13.14.2.2. Adipose Tissue 13.14.2.3. Blood 13.14.3. Syngeneic 13.14.4. Other 13.15. Germany Stem Cell Reconstructive Market Forecast, By Cell Type 13.15.1. Embryonic Stem Cell 13.15.2. Adult Stem Cell 13.16. Germany Stem Cell Reconstructive Market Forecast, By End-User 13.16.1. Hospitals 13.16.2. Research Institute 13.16.3. Others 13.17. Germany Stem Cell Reconstructive Market Forecast, By Application 13.17.1. Cancer 13.17.2. Diabetes 13.17.3. Traumatic Skin Defect 13.17.4. Severe Burn 13.17.5. Other 13.18. U.K. Stem Cell Reconstructive Market Forecast, By Sources 13.18.1. Allogeneic 13.18.2. Autologous 13.18.2.1. Bone Marrow 13.18.2.2. Adipose Tissue 13.18.2.3. Blood 13.18.3. Syngeneic 13.18.4. Other 13.19. U.K. Stem Cell Reconstructive Market Forecast, By Cell Type 13.19.1. Embryonic Stem Cell 13.19.2. Adult Stem Cell 13.20. U.K. Stem Cell Reconstructive Market Forecast, By End-User 13.20.1. Hospitals 13.20.2. Research Institute 13.20.3. Others 13.21. U.K. Stem Cell Reconstructive Market Forecast, By Application 13.21.1. Cancer 13.21.2. Diabetes 13.21.3. Traumatic Skin Defect 13.21.4. Severe Burn 13.21.5. Other 13.22. France Stem Cell Reconstructive Market Forecast, By Sources 13.22.1. Allogeneic 13.22.2. Autologous 13.22.2.1. Bone Marrow 13.22.2.2. Adipose Tissue 13.22.2.3. Blood 13.22.3. Syngeneic 13.22.4. Other 13.23. France Stem Cell Reconstructive Market Forecast, By Cell Type 13.23.1. Embryonic Stem Cell 13.23.2. Adult Stem Cell 13.24. France Stem Cell Reconstructive Market Forecast, By End-User 13.24.1. Hospitals 13.24.2. Research Institute 13.24.3. Others 13.25. France Stem Cell Reconstructive Market Forecast, By Application 13.25.1. Cancer 13.25.2. Diabetes 13.25.3. Traumatic Skin Defect 13.25.4. Severe Burn 13.25.5. Other 13.26. Italy Stem Cell Reconstructive Market Forecast, By Sources 13.26.1. Allogeneic 13.26.2. Autologous 13.26.2.1. Bone Marrow 13.26.2.2. Adipose Tissue 13.26.2.3. Blood 13.26.3. Syngeneic 13.26.4. Other 13.27. Italy Stem Cell Reconstructive Market Forecast, By Cell Type 13.27.1. Embryonic Stem Cell 13.27.2. Adult Stem Cell 13.28. Italy Stem Cell Reconstructive Market Forecast, By End-User 13.28.1. Hospitals 13.28.2. Research Institute 13.28.3. Others 13.29. Italy Stem Cell Reconstructive Market Forecast, By Application 13.29.1. Cancer 13.29.2. Diabetes 13.29.3. Traumatic Skin Defect 13.29.4. Severe Burn 13.29.5. Other 13.30. Spain Stem Cell Reconstructive Market Forecast, By Sources 13.30.1. Allogeneic 13.30.2. Autologous 13.30.2.1. Bone Marrow 13.30.2.2. Adipose Tissue 13.30.2.3. Blood 13.30.3. Syngeneic 13.30.4. Other 13.31. Spain Stem Cell Reconstructive Market Forecast, By Cell Type 13.31.1. Embryonic Stem Cell 13.31.2. Adult Stem Cell 13.32. Spain Stem Cell Reconstructive Market Forecast, By End-User 13.32.1. Hospitals 13.32.2. Research Institute 13.32.3. Others 13.33. Spain Stem Cell Reconstructive Market Forecast, By Application 13.33.1. Cancer 13.33.2. Diabetes 13.33.3. Traumatic Skin Defect 13.33.4. Severe Burn 13.33.5. Other 13.34. Rest of Europe Stem Cell Reconstructive Market Forecast, By Sources 13.34.1. Allogeneic 13.34.2. Autologous 13.34.2.1. Bone Marrow 13.34.2.2. Adipose Tissue 13.34.2.3. Blood 13.34.3. Syngeneic 13.34.4. Other 13.35. Rest of Europe Stem Cell Reconstructive Market Forecast, By Cell Type 13.35.1. Embryonic Stem Cell 13.35.2. Adult Stem Cell 13.36. Rest of Europe Stem Cell Reconstructive Market Forecast, By End-User 13.36.1. Hospitals 13.36.2. Research Institute 13.36.3. Others 13.37. Rest Of Europe Stem Cell Reconstructive Market Forecast, By Application 13.37.1. Cancer 13.37.2. Diabetes 13.37.3. Traumatic Skin Defect 13.37.4. Severe Burn 13.37.5. Other 13.38. Europe Stem Cell Reconstructive Market Attractiveness Analysis 13.38.1. By Sources 13.38.2. By Cell Type 13.38.3. By End-User 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Stem Cell Reconstructive Market Analysis 14.1. Key Findings 14.2. Asia Pacific Stem Cell Reconstructive Market Overview 14.3. Asia Pacific Stem Cell Reconstructive Market Value Share Analysis, By Sources 14.4. Asia Pacific Stem Cell Reconstructive Market Forecast, By Sources 14.4.1. Allogeneic 14.4.2. Autologous 14.4.2.1. Bone Marrow 14.4.2.2. Adipose Tissue 14.4.2.3. Blood 14.4.3. Syngeneic 14.4.4. Other 14.5. Asia Pacific Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 14.6. Asia Pacific Stem Cell Reconstructive Market Forecast, By Cell Type 14.6.1. Embryonic Stem Cell 14.6.2. Adult Stem Cell 14.7. Asia Pacific Stem Cell Reconstructive Market Value Share Analysis, By End-User 14.8. Asia Pacific Stem Cell Reconstructive Market Forecast, By End-User 14.8.1. Hospitals 14.8.2. Research Institute 14.8.3. Others 14.9. Asia Pacific Stem Cell Reconstructive Market Value Share Analysis, By Application 14.10. Asia Pacific Stem Cell Reconstructive Market Forecast, By Application 14.10.1. Cancer 14.10.2. Diabetes 14.10.3. Traumatic Skin Defect 14.10.4. Severe Burn 14.10.5. Other 14.11. Asia Pacific Stem Cell Reconstructive Market Value Share Analysis, by Country 14.12. Asia Pacific Stem Cell Reconstructive Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Stem Cell Reconstructive Market Analysis, by Country 14.14. China Stem Cell Reconstructive Market Forecast, By Sources 14.14.1. Allogeneic 14.14.2. Autologous 14.14.2.1. Bone Marrow 14.14.2.2. Adipose Tissue 14.14.2.3. Blood 14.14.3. Syngeneic 14.14.4. Other 14.15. China Stem Cell Reconstructive Market Forecast, By Cell Type 14.15.1. Embryonic Stem Cell 14.15.2. Adult Stem Cell 14.16. China Stem Cell Reconstructive Market Forecast, By End-User 14.16.1. Hospitals 14.16.2. Research Institute 14.16.3. Others 14.17. China Stem Cell Reconstructive Market Forecast, By Application 14.17.1. Cancer 14.17.2. Diabetes 14.17.3. Traumatic Skin Defect 14.17.4. Severe Burn 14.17.5. Other 14.18. India Stem Cell Reconstructive Market Forecast, By Sources 14.18.1. Allogeneic 14.18.2. Autologous 14.18.2.1. Bone Marrow 14.18.2.2. Adipose Tissue 14.18.2.3. Blood 14.18.3. Syngeneic 14.18.4. Other 14.19. India Stem Cell Reconstructive Market Forecast, By Cell Type 14.19.1. Embryonic Stem Cell 14.19.2. Adult Stem Cell 14.20. India Stem Cell Reconstructive Market Forecast, By End-User 14.20.1. Hospitals 14.20.2. Research Institute 14.20.3. Others 14.21. India Stem Cell Reconstructive Market Forecast, By Application 14.21.1. Cancer 14.21.2. Diabetes 14.21.3. Traumatic Skin Defect 14.21.4. Severe Burn 14.21.5. Other 14.22. Japan Stem Cell Reconstructive Market Forecast, By Sources 14.22.1. Allogeneic 14.22.2. Autologous 14.22.2.1. Bone Marrow 14.22.2.2. Adipose Tissue 14.22.2.3. Blood 14.22.3. Syngeneic 14.22.4. Other 14.23. Japan Stem Cell Reconstructive Market Forecast, By Cell Type 14.23.1. Embryonic Stem Cell 14.23.2. Adult Stem Cell 14.24. Japan Stem Cell Reconstructive Market Forecast, By End-User 14.24.1. Hospitals 14.24.2. Research Institute 14.24.3. Others 14.25. Japan Stem Cell Reconstructive Market Forecast, By Application 14.25.1. Cancer 14.25.2. Diabetes 14.25.3. Traumatic Skin Defect 14.25.4. Severe Burn 14.25.5. Other 14.26. ASEAN Stem Cell Reconstructive Market Forecast, By Sources 14.26.1. Allogeneic 14.26.2. Autologous 14.26.2.1. Bone Marrow 14.26.2.2. Adipose Tissue 14.26.2.3. Blood 14.26.3. Syngeneic 14.26.4. Other 14.27. ASEAN Stem Cell Reconstructive Market Forecast, By Cell Type 14.27.1. Embryonic Stem Cell 14.27.2. Adult Stem Cell 14.28. ASEAN Stem Cell Reconstructive Market Forecast, By End-User 14.28.1. Hospitals 14.28.2. Research Institute 14.28.3. Others 14.29. ASEAN Stem Cell Reconstructive Market Forecast, By Application 14.29.1. Cancer 14.29.2. Diabetes 14.29.3. Traumatic Skin Defect 14.29.4. Severe Burn 14.29.5. Other 14.30. Rest of Asia Pacific Stem Cell Reconstructive Market Forecast, By Sources 14.30.1. Allogeneic 14.30.2. Autologous 14.30.2.1. Bone Marrow 14.30.2.2. Adipose Tissue 14.30.2.3. Blood 14.30.3. Syngeneic 14.30.4. Other 14.31. Rest of Asia Pacific Stem Cell Reconstructive Market Forecast, By Cell Type 14.31.1. Embryonic Stem Cell 14.31.2. Adult Stem Cell 14.32. Rest of Asia Pacific Stem Cell Reconstructive Market Forecast, By End-User 14.32.1. Hospitals 14.32.2. Research Institute 14.32.3. Others 14.33. Rest of Asia Pacific Stem Cell Reconstructive Market Forecast, By Application 14.33.1. Cancer 14.33.2. Diabetes 14.33.3. Traumatic Skin Defect 14.33.4. Severe Burn 14.33.5. Other 14.34. Asia Pacific Stem Cell Reconstructive Market Attractiveness Analysis 14.34.1. By Sources 14.34.2. By Cell Type 14.34.3. By End-User 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Stem Cell Reconstructive Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Stem Cell Reconstructive Market Overview 15.3. Middle East & Africa Stem Cell Reconstructive Market Value Share Analysis, By Sources 15.4. Middle East & Africa Stem Cell Reconstructive Market Forecast, By Sources 15.4.1. Allogeneic 15.4.2. Autologous 15.4.2.1. Bone Marrow 15.4.2.2. Adipose Tissue 15.4.2.3. Blood 15.4.3. Syngeneic 15.4.4. Other 15.5. Middle East & Africa Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 15.6. Middle East & Africa Stem Cell Reconstructive Market Forecast, By Cell Type 15.6.1. Embryonic Stem Cell 15.6.2. Adult Stem Cell 15.7. Middle East & Africa Stem Cell Reconstructive Market Value Share Analysis, By End-User 15.8. Middle East & Africa Stem Cell Reconstructive Market Forecast, By End-User 15.8.1. Hospitals 15.8.2. Research Institute 15.8.3. Others 15.9. Middle East & Africa Stem Cell Reconstructive Market Value Share Analysis, By Application 15.10. Middle East & Africa Stem Cell Reconstructive Market Forecast, By Application 15.10.1. Cancer 15.10.2. Diabetes 15.10.3. Traumatic Skin Defect 15.10.4. Severe Burn 15.10.5. Other 15.11. Middle East & Africa Stem Cell Reconstructive Market Value Share Analysis, by Country 15.12. Middle East & Africa Stem Cell Reconstructive Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Stem Cell Reconstructive Market Analysis, by Country 15.14. GCC Stem Cell Reconstructive Market Forecast, By Sources 15.14.1. Allogeneic 15.14.2. Autologous 15.14.2.1. Bone Marrow 15.14.2.2. Adipose Tissue 15.14.2.3. Blood 15.14.3. Syngeneic 15.14.4. Other 15.15. GCC Stem Cell Reconstructive Market Forecast, By Cell Type 15.15.1. Embryonic Stem Cell 15.15.2. Adult Stem Cell 15.16. GCC Stem Cell Reconstructive Market Forecast, By End-User 15.16.1. Hospitals 15.16.2. Research Institute 15.16.3. Others 15.17. GCC Stem Cell Reconstructive Market Forecast, By Application 15.17.1. Cancer 15.17.2. Diabetes 15.17.3. Traumatic Skin Defect 15.17.4. Severe Burn 15.17.5. Other 15.18. South Africa Stem Cell Reconstructive Market Forecast, By Sources 15.18.1. Allogeneic 15.18.2. Autologous 15.18.2.1. Bone Marrow 15.18.2.2. Adipose Tissue 15.18.2.3. Blood 15.18.3. Syngeneic 15.18.4. Other 15.19. South Africa Stem Cell Reconstructive Market Forecast, By Cell Type 15.19.1. Embryonic Stem Cell 15.19.2. Adult Stem Cell 15.20. South Africa Stem Cell Reconstructive Market Forecast, By End-User 15.20.1. Hospitals 15.20.2. Research Institute 15.20.3. Others 15.21. South Africa Stem Cell Reconstructive Market Forecast, By Application 15.21.1. Cancer 15.21.2. Diabetes 15.21.3. Traumatic Skin Defect 15.21.4. Severe Burn 15.21.5. Other 15.22. Rest of Middle East & Africa Stem Cell Reconstructive Market Forecast, By Sources 15.22.1. Allogeneic 15.22.2. Autologous 15.22.2.1. Bone Marrow 15.22.2.2. Adipose Tissue 15.22.2.3. Blood 15.22.3. Syngeneic 15.22.4. Other 15.23. Rest of Middle East & Africa Stem Cell Reconstructive Market Forecast, By Cell Type 15.23.1. Embryonic Stem Cell 15.23.2. Adult Stem Cell 15.24. Rest of Middle East & Africa Stem Cell Reconstructive Market Forecast, By End-User 15.24.1. Hospitals 15.24.2. Research Institute 15.24.3. Others 15.25. Rest of Middle East & Africa Stem Cell Reconstructive Market Forecast, By Application 15.25.1. Cancer 15.25.2. Diabetes 15.25.3. Traumatic Skin Defect 15.25.4. Severe Burn 15.25.5. Other 15.26. Middle East & Africa Stem Cell Reconstructive Market Attractiveness Analysis 15.26.1. By Sources 15.26.2. By Cell Type 15.26.3. By End-User 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Stem Cell Reconstructive Market Analysis 16.1. Key Findings 16.2. South America Stem Cell Reconstructive Market Overview 16.3. South America Stem Cell Reconstructive Market Value Share Analysis, By Sources 16.4. South America Stem Cell Reconstructive Market Forecast, By Sources 16.4.1. Allogeneic 16.4.2. Autologous 16.4.2.1. Bone Marrow 16.4.2.2. Adipose Tissue 16.4.2.3. Blood 16.4.3. Syngeneic 16.4.4. Other 16.5. South America Stem Cell Reconstructive Market Value Share Analysis, By Cell Type 16.6. South America Stem Cell Reconstructive Market Forecast, By Cell Type 16.6.1. Embryonic Stem Cell 16.6.2. Adult Stem Cell 16.7. South America Stem Cell Reconstructive Market Value Share Analysis, By End-User 16.8. South America Stem Cell Reconstructive Market Forecast, By End-User 16.8.1. Hospitals 16.8.2. Research Institute 16.8.3. Others 16.9. South America Stem Cell Reconstructive Market Value Share Analysis, By Application 16.10. South America Stem Cell Reconstructive Market Forecast, By Application 16.10.1. Cancer 16.10.2. Diabetes 16.10.3. Traumatic Skin Defect 16.10.4. Severe Burn 16.10.5. Other 16.11. South America Stem Cell Reconstructive Market Value Share Analysis, by Country 16.12. South America Stem Cell Reconstructive Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Stem Cell Reconstructive Market Analysis, by Country 16.14. Brazil Stem Cell Reconstructive Market Forecast, By Sources 16.14.1. Allogeneic 16.14.2. Autologous 16.14.2.1. Bone Marrow 16.14.2.2. Adipose Tissue 16.14.2.3. Blood 16.14.3. Syngeneic 16.14.4. Other 16.15. Brazil Stem Cell Reconstructive Market Forecast, By Cell Type 16.15.1. Embryonic Stem Cell 16.15.2. Adult Stem Cell 16.16. Brazil Stem Cell Reconstructive Market Forecast, By End-User 16.16.1. Hospitals 16.16.2. Research Institute 16.16.3. Others 16.17. Brazil Stem Cell Reconstructive Market Forecast, By Application 16.17.1. Cancer 16.17.2. Diabetes 16.17.3. Traumatic Skin Defect 16.17.4. Severe Burn 16.17.5. Other 16.18. Mexico Stem Cell Reconstructive Market Forecast, By Sources 16.18.1. Allogeneic 16.18.2. Autologous 16.18.2.1. Bone Marrow 16.18.2.2. Adipose Tissue 16.18.2.3. Blood 16.18.3. Syngeneic 16.18.4. Other 16.19. Mexico Stem Cell Reconstructive Market Forecast, By Cell Type 16.19.1. Embryonic Stem Cell 16.19.2. Adult Stem Cell 16.20. Mexico Stem Cell Reconstructive Market Forecast, By End-User 16.20.1. Hospitals 16.20.2. Research Institute 16.20.3. Others 16.21. Mexico Stem Cell Reconstructive Market Forecast, By Application 16.21.1. Cancer 16.21.2. Diabetes 16.21.3. Traumatic Skin Defect 16.21.4. Severe Burn 16.21.5. Other 16.22. Rest of South America Stem Cell Reconstructive Market Forecast, By Sources 16.22.1. Allogeneic 16.22.2. Autologous 16.22.2.1. Bone Marrow 16.22.2.2. Adipose Tissue 16.22.2.3. Blood 16.22.3. Syngeneic 16.22.4. Other 16.23. Rest of South America Stem Cell Reconstructive Market Forecast, By Cell Type 16.23.1. Embryonic Stem Cell 16.23.2. Adult Stem Cell 16.24. Rest of South America Stem Cell Reconstructive Market Forecast, By End-User 16.24.1. Hospitals 16.24.2. Research Institute 16.24.3. Others 16.25. Rest of South America Stem Cell Reconstructive Market Forecast, By Application 16.25.1. Cancer 16.25.2. Diabetes 16.25.3. Traumatic Skin Defect 16.25.4. Severe Burn 16.25.5. Other 16.26. South America Stem Cell Reconstructive Market Attractiveness Analysis 16.26.1. By Sources 16.26.2. By Cell Type 16.26.3. By End-User 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.4. M&A by Regions, Investment and Applications 17.2.5. M&A Key Players, Forward Integration and Backward 17.2.6. Integration 17.3. Company Profiles: Key Players 17.3.1. Osiris Therapeutics 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. NuVasive 17.3.3. Cytori Therapeutics 17.3.4. Takeda (TiGenix) 17.3.5. Cynata 17.3.6. Celyad 17.3.7. Medi-post 17.3.8. Anterogen 17.3.9. Molmed 17.3.10. Baxter 17.3.11. Eleveflow 17.3.12. Mesoblast Ltd. 17.3.13. Micronit Microfluidics 17.3.14. TAKARA BIO INC. 17.3.15. Tigenix 17.3.16. Capricor Therapeutics 17.3.17. Astellas Pharma US, Inc. 17.3.18. Pfizer Inc. 17.3.19. STEMCELL Technologies Inc. 17.3.20. Pfizer Inc. 17.3.21. StemCells Inc 17.3.22. Caladrius 18. Primary Key Insights